BACKGROUND: Childhood obesity and overweight affect approximately 30% of US children. Many of these children have obesity-related comorbidities, such as hypertension, dyslipidemia, fatty liver disease, diabetes, polycystic ovary syndrome (PCOS), sleep apnea, psychosocial problems, and others. These children need routine screening and, in many cases, treatment for these conditions. However, because primary care pediatric providers (PCPs) often are underequipped to deal with these comorbidities, they frequently refer these patients to subspecialists. However, as a result of the US pediatric subspecialist shortage and considering that 12.5 million children are obese, access to care by subspecialists is limited. The aim of this article is to provide accessible, user-friendly clinical consensus statements to facilitate the screening, interpretation of results, and early treatment for some of the most common childhood obesity comorbidities. METHODS: Members of the Children's Hospital Association (formerly NACHRI) FOCUS on a Fitter Future II (FFFII), a collaboration of 25 US pediatric obesity centers, used a combination of the best available evidence and collective clinical experience to develop consensus statements for pediatric obesity-related comorbidities. FFFII also surveyed the participating pediatric obesity centers regarding their current practices. RESULTS: The work group developed consensus statements for use in the evaluation and treatment of lipids, liver enzymes, and blood pressure abnormalities and PCOS in the child with overweight and obesity. The results of the FFFII survey illustrated the variability in the approach for initial evaluation and treatment as well as pattern of referrals to subspecialists among programs. CONCLUSIONS: The consensus statements presented in this article can be a useful tool for PCPs in the management and overall care of children with overweight and obesity.
BACKGROUND: Childhood obesity and overweight affect approximately 30% of US children. Many of these children have obesity-related comorbidities, such as hypertension, dyslipidemia, fatty liver disease, diabetes, polycystic ovary syndrome (PCOS), sleep apnea, psychosocial problems, and others. These children need routine screening and, in many cases, treatment for these conditions. However, because primary care pediatric providers (PCPs) often are underequipped to deal with these comorbidities, they frequently refer these patients to subspecialists. However, as a result of the US pediatric subspecialist shortage and considering that 12.5 million children are obese, access to care by subspecialists is limited. The aim of this article is to provide accessible, user-friendly clinical consensus statements to facilitate the screening, interpretation of results, and early treatment for some of the most common childhood obesity comorbidities. METHODS: Members of the Children's Hospital Association (formerly NACHRI) FOCUS on a Fitter Future II (FFFII), a collaboration of 25 US pediatric obesity centers, used a combination of the best available evidence and collective clinical experience to develop consensus statements for pediatric obesity-related comorbidities. FFFII also surveyed the participating pediatric obesity centers regarding their current practices. RESULTS: The work group developed consensus statements for use in the evaluation and treatment of lipids, liver enzymes, and blood pressure abnormalities and PCOS in the child with overweight and obesity. The results of the FFFII survey illustrated the variability in the approach for initial evaluation and treatment as well as pattern of referrals to subspecialists among programs. CONCLUSIONS: The consensus statements presented in this article can be a useful tool for PCPs in the management and overall care of children with overweight and obesity.
Authors: Mark R Palmert; Catherine M Gordon; Alex I Kartashov; Richard S Legro; S Jean Emans; Andrea Dunaif Journal: J Clin Endocrinol Metab Date: 2002-03 Impact factor: 5.958
Authors: Jeffrey B Schwimmer; Winston Dunn; Gregory J Norman; Perrie E Pardee; Michael S Middleton; Nanda Kerkar; Claude B Sirlin Journal: Gastroenterology Date: 2010-01-11 Impact factor: 22.682
Authors: Kelsey E S Salley; Edmond P Wickham; Kai I Cheang; Paulina A Essah; Nicole W Karjane; John E Nestler Journal: J Clin Endocrinol Metab Date: 2007-12 Impact factor: 5.958
Authors: Melawhy L Garcia; Noe C Crespo; Alma I Behar; Gregory A Talavera; Nadia Campbell; Lisa M Shadron; John P Elder Journal: Child Obes Date: 2019-09-26 Impact factor: 2.992
Authors: Teresa Schwendler; Cara Shipley; Nadine Budd; Angela Trude; Pamela J Surkan; Elizabeth Anderson Steeves; Priscila de Morais Sato; Thomas Eckmann; Hong Loh; Joel Gittelsohn Journal: Health Promot Pract Date: 2017-03-26
Authors: Janna B Howard; Asheley Cockrell Skinner; Sophie N Ravanbakht; Jane D Brown; Andrew J Perrin; Michael J Steiner; Eliana M Perrin Journal: Pediatrics Date: 2017-12 Impact factor: 7.124
Authors: Joanna Bartkowiak; Ernest Spitzer; Reto Kurmann; Fabian Zürcher; Peter Krähenmann; Victoria Garcia-Ruiz; Jorge Mercado; Christoph Ryffel; Sylvain Losdat; Nassip Llerena; Pedro Torres; Jonas Lanz; Martin Stocker; Ben Ren; Martin Glöckler; Thomas Pilgrim Journal: Sci Rep Date: 2021-06-22 Impact factor: 4.379